NCT05310812View on ClinicalTrials.gov

Evaluation of Candidate Biomarkers to Predict Disease Severity and Acute Kidney Injury in Sepsis Patients

CompletedOBSERVATIONAL

Enrollment

140

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

November 29, 2022

Conditions

SepsisSeptic ShockAcute Kidney Injury

Interventions

DIAGNOSTIC_TEST

Biochemical evaluation.

Blood will be taken for biochemical evaluation-ELISA.

Trial Locations (1)

34093

Istanbul University, Istanbul Faculy of Medicine, Istanbul

All Listed Sponsors

lead

Istanbul University

OTHER

NCT05310812 - Evaluation of Candidate Biomarkers to Predict Disease Severity and Acute Kidney Injury in Sepsis Patients | Biotech Hunter | Biotech Hunter